secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2023-08-31T23:59:59+00:00
Accession:  0001213900-23-072838
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive Therapeutics appoints Grassi & Co. as new auditor effective Aug 28, 2023
--------------------------------------------------------------------------------

- Grassi & Co. CPAs, P.C. appointed as independent registered public accounting firm on Aug 28, 2023, subject to client acceptance.
- Appointment follows resignation of prior auditor Mayer Hoffman McCann P.C., disclosed on July 31, 2023.
- No prior consultations with Grassi on accounting principles or audit opinions during 2022 or through June 30, 2023.
- No disagreements or reportable events occurred between company and previous auditor.
- Audit Committee approved the appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023072838/0001213900-23-072838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023072838/ea184501-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-072838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer